HI homepage

UnitedHealth Group - 2
Practice says paltry UnitedHealthcare rates making it difficult to recruit radiologists

Chattanooga-based Tennessee Interventional and Imaging Associates has pushed the country’s largest commercial payer to up its rates to match other larger communities such as Memphis and Nashville.    

merger acquisition M&A business
Radiology Partners sells 2 imaging centers to New Jersey private practice

RP is selling outposts in the communities of Hamilton Township and Lawrenceville, both near the Garden State’s capital city of Trenton, to Princeton Radiology. 

Thumbnail
Vetting imaging orders for appropriateness represents a 'substantial hidden workload,' new data show

This practice ensures patients undergo imaging that is appropriate for their clinical indication and reduces the likelihood of unnecessary exams being completed.

Thumbnail
CIVIE expanding its teleradiology footprint in Midwest

Riverside Healthcare, which provides radiology services to six different locations throughout Kankakee, Illinois, is turning to CIVIE to integrate the company’s teleradiology services via its RadPod platform.

Blue Cross Blue Shield Association BCBS
Health insurer Highmark will provide 100% coverage for all diagnostic breast imaging

The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”

carestream
Carestream sells off international business lines to improve balance sheet

Under terms of the deal, Carestream is unloading its international operations to Midea Group, a Chinese electrical appliance manufacturer. 

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.